Activation of β-adrenergic receptor promotes cellular proliferation in human glioblastoma
Authors:
- 21 July 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 14 (3) , 3846-3852
Abstract
Glioblastoma multiforme is the most common and aggressive form of primary malignant brain tumor. Previous evidence demonstrates that β‑adrenergic receptors (β‑ARs) are closely associated with the occurrence and development of brain tumors. However, the functional role of β‑ARs in human glioblastoma and the underlying mechanisms are not fully understood. In the present study, by using the MTT assay, western blotting, and the reverse transcription polymerase chain reaction, it was revealed that isoproterenol (ISO), an agonist of β‑ARs, promoted the proliferation of U251 cells but not U87‑MG cells, and that this effect was blocked by the β‑ARs antagonist propranolol. It was also demonstrated that ISO transiently induced extracellular signal‑related kinase 1/2 (ERK1/2) phosphorylation, and that blocking the mitogen-activated protein kinase pathway by U0126 inhibited ERK1/2 phosphorylation and suppressed U251 cell proliferation. In addition, β‑ARs activation increased the expression of matrix metalloproteinase (MMP) family members MMP‑2 and MMP‑9 mRNA through ERK1/2 activation. In conclusion, these data suggest that β‑ARs induce ERK1/2 phosphorylation, which may in turn increase MMPs expression to promote U251 cell proliferation. These results provide additional insight into the specific roles of β‑ARs in glioblastoma.Keywords
This publication has 44 references indexed in Scilit:
- Behavioral stress accelerates prostate cancer development in miceJournal of Clinical Investigation, 2013
- β2-Adrenergic Receptor Agonists Inhibit the Proliferation of 1321N1 Astrocytoma CellsThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Ligand‐directed signalling at β‐adrenoceptorsBritish Journal of Pharmacology, 2010
- Neurotransmitter Receptors as Central Regulators of Pancreatic CancerFuture Oncology, 2010
- Prevention of pancreatic cancer by the beta-blocker propranololAnti-Cancer Drugs, 2009
- GABAB receptor is a novel drug target for pancreatic cancerCancer, 2008
- Psychological Stress and DiseaseJAMA, 2007
- Stress and the brain: from adaptation to diseaseNature Reviews Neuroscience, 2005
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001